Abstracts

PREPARING FOR THE PLATE OF PREVENTION OPTIONS: HOW CAN WE DELIVER?

HIV prevention has been revolutionized by biomedical advances in pre-exposure prophylaxis (PrEP) which has changed the trajectory of the HIV epidemic in areas with high uptake. PrEP with daily oral tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) was first shown to be effective for HIV prevention in the iPrEx study more than a decade ago, however…

APPLYING LESSONS LEARNED FROM CONTRACEPTION TO PrEP

In this presentation, we will discuss lessons learned from the history of contraception, and apply them to PrEP and specifically the use of longer acting PrEP. We will review best practices in offering PrEP methods in a person-centered manner, with the goal of aligning selected methods with the values and preferences of the patient or…

NEW INSIGHTS INTO HIV RNA BIOLOGY

HIV-1 RNAs play essential roles in nearly every aspect of viral replication and are targets of synthetic and natural cellular antiviral inhibitors. Over the past decade, studies employing a variety of technological approaches have led to insights into the structural and mechanistic bases for RNA-dependent activities important for viral replication. Molecular determinants of virus restriction…

UNDERSTANDING THE EPIDEMIOLOGY OF COVID-19: A GLOBAL PERSPECTIVE

This keynote talk will provide an overview of the global epidemiology of COVID-19, mainly focusing on disparities in transmission, severity, and outcomes. It will also summarise the challenging and often misinterpreted but consequential epidemiological aspects such as asymptomatic transmission, changes in the severity of disease and transmissibility of variants, and the role of children in…

CHILDREN EXPOSED TO HIV, BUT UNINFECTED: EVIDENCE FOR ACTION

Due to the success in preventing vertical transmission of HIV, there is an expanding global population of children who are HIV-exposed but uninfected (CHEU). Prior to the availability of antiretroviral therapy (ART) for pregnant and breastfeeding women, CHEU had evidence of excess mortality, morbidity and growth failure compared to children who are HIV-unexposed (CHU), particularly…

HIV-1 MATURATION – NEW VIEWS OF AN EXTRAORDINARY METAMORPHOSIS

HIV-1 is released from an infected cell in an immature form, before proteolytic cleavage of viral polyproteins by the viral protease triggers rearrangement of the virus into its mature, infectious form. Prior to maturation, the components of the virus are optimised for assembly – they collect all the required components at the assembly site, and…